Two Republican senators have asked the FDA for data about the effect of a drug that inhibits puberty, which was recently mentioned by medical professionals.
GOP Senators. Marsha Blackburn of Tennessee and Cynthia Lummis of Wyoming wrote a letter to FDA Commissioner Robert Califf on Thursday about the side-effects of gonadotropin-releasing hormone (GnRH) agonists, which are used to treat minors with early-onset puberty, as well as stave off the normal pubescent development of minors who may be considering sex-reassignment surgery.
FDA has issued warnings about GnRH-agonists after pseudotumor cerebri was reported. It is a condition which mimics a brain tumour but does not have a clear source. GnRH agonists may be found in drug such as Lupron Depot Ped and Fensolvi. Synarel, SupprelinLA, Triptodur, and Synarel.
Senators pointed out that GnRH antagonists can be used by children with developmental disorders like central precocious (CPP), in which a child experiences puberty earlier than usual, but the drug has not been approved to treat gender dysphoric and transgender patients. GnRH should be used for the initial treatment of gender dysphoria in minors, according to an article published by National Library of Medicine.
“[T]he off-label use of GnRH agonists in connection with diagnoses of gender dysphoria or the provision of transgender care is, by definition, intended to suppress the normal biological processes of puberty beyond the normal age of onset. Given that such off-label use deliberately delays and alters normal development, We are deeply concerned that it could result in significant short-term and long-term risks and adverse effects on adolescent patients,”They wrote.
“Our concern has been heightened by reports of increased off-label use of GnRH agonists in connection with transgender care,”They added. These people then asked for trial data, side-effects reports, and information regarding GnRH antagons.
Blackburn and Lummis’ letter comes days after Daily Wire host Matt Walsh posted shocking videos of a doctor at a Transgender Clinic at Vanderbilt University Medical promoting transgender surgeries as a “big money maker.”Doctor who commented works with adults.
Transgender procedures and minor treatment are also described by the medical center. A video from Vanderbilt Psychiatry YouTube channels shows how the center works. “explicitly [admits] that they will give and have given irreversible hormone drugs to children as young as 13,”Walsh wrote.
The university released a statement after Walsh’s report claiming that reports of its transgender care “misrepresented facts.”
“We have been and will continue to be committed to providing family-centered care to all adolescents in compliance with state law and in line with professional practice standards and guidance established by medical specialty societies,”The statement was as follows:
Blackburn has joined other Tennessee officials in calling for an investigation into Vanderbilt University Medical in the wake of Walsh’s reporting.
“Using children for profit and political gain is deeply disturbing. Experts agree that there have not been enough clinical trials conducted to prove the safety and effectiveness of using these drugs on kids,”Blackburn stated in a statement. “These drugs have not been approved for treating children experiencing gender dysphoria, but the left insists on experimenting on these children anyway.”
This report was contributed by Zach Jewell
Check out the complete article here